Holen Sie sich die Stockscreener-App
13.10
0.08%
0.010
Vorhandelsmarkt:
13.15
0.05
+0.38%
Schlusskurs vom Vortag:
$13.09
Offen:
$13.09
24-Stunden-Volumen:
2.65M
Relative Volume:
1.42
Marktkapitalisierung:
$747.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-72.89M
KGV:
-5.4132
EPS:
-2.42
Netto-Cashflow:
$-68.47M
1W Leistung:
+3.97%
1M Leistung:
+6.94%
6M Leistung:
+148.11%
1J Leistung:
+29.19%
1-Tages-Spanne:
$13.06
$13.29
1-Wochen-Bereich:
$12.55
$13.29
52-Wochen-Spanne:
$3.555
$13.29
Astria Therapeutics Inc Stock (ATXS) Company Profile
Firmenname
Astria Therapeutics Inc
Sektor
Branche
Telefon
617-349-1971
Adresse
22 BOSTON WHARF ROAD, BOSTON
Vergleichen Sie ATXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATXS
Astria Therapeutics Inc
|
13.10 | 747.24M | 0 | -72.89M | -68.47M | -2.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-09-17 | Bestätigt | H.C. Wainwright | Buy |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-31 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-07-29 | Eingeleitet | TD Cowen | Buy |
| 2023-03-28 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Astria Therapeutics Inc Aktie (ATXS) Neueste Nachrichten
Will Astria Therapeutics Inc. stock gain from government policies2025 Market Overview & Verified Swing Trading Watchlists - Newser
Astria Therapeutics (NASDAQ:ATXS) Sees Large Volume IncreaseWhat's Next? - MarketBeat
BioCryst’s Ongoing Boost: Buy or Watch? - StocksToTrade
Astria Therapeutics (NASDAQ:ATXS) Sets New 1-Year HighWhat's Next? - MarketBeat
Astria Therapeutics (ATXS) Acquisition Moves Forward with Antitr - GuruFocus
BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition - The Manila Times
BioCryst Pharmaceuticals Announces Early Termination of HSR Waiting Period for Astria Therapeutics Acquisition - Quiver Quantitative
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-TCBX, RNA, ATXS, and FSUN - The Malaysian Reserve
Trading the Move, Not the Narrative: (ATXS) Edition - news.stocktradersdaily.com
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN - sahmcapital.com
Astria Therapeutics: Updating Target Price, BioCryst Deal Expected To Go Through, Hold - Seeking Alpha
Why Astria Therapeutics Inc. stock could outperform in 2025Weekly Trade Summary & High Accuracy Buy Signal Tips - moha.gov.vn
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment - MSN
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-SPNS, PCH, ATXS, and RYN - The Malaysian Reserve
Halper Sadeh LLC Encourages ATXS, PCH, RYN Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
(ATXS) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Will Astria Therapeutics Inc. stock split again soonJuly 2025 Summary & High Yield Equity Trading Tips - newser.com
How Astria Therapeutics Inc. stock performs in interest rate cycles2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
Will Astria Therapeutics Inc. stock deliver consistent dividendsJuly 2025 Review & Weekly High Potential Alerts - newser.com
Can Astria Therapeutics Inc. stock deliver surprise earnings beatWeekly Stock Analysis & Fast Momentum Stock Entry Tips - newser.com
Can Astria Therapeutics Inc. stock outperform in 2025 bull marketPortfolio Return Summary & Detailed Earnings Play Alerts - newser.com
Combining price and volume data for Astria Therapeutics Inc.2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Why Astria Therapeutics Inc. is moving todayJuly 2025 Earnings & Reliable Momentum Entry Alerts - newser.com
Is this a good reentry point in Astria Therapeutics Inc.2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com
Will Astria Therapeutics Inc. stock deliver shareholder valueEarnings Risk Report & AI Driven Stock Reports - newser.com
Is Astria Therapeutics Inc. stock a contrarian buyJuly 2025 Technicals & High Conviction Buy Zone Alerts - newser.com
Is Astria Therapeutics Inc. stock overvalued by current metrics2025 Price Action Summary & High Return Trade Guides - newser.com
Astria Therapeutics Inc. (ATXS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Astria Therapeutics Inc. stock is in analyst buy zoneQuarterly Trade Report & Breakout Confirmation Alerts - newser.com
Multi factor analysis applied to Astria Therapeutics Inc.Quarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
Is Astria Therapeutics Inc. trending in predictive chart modelsGDP Growth & Community Verified Trade Signals - newser.com
Will Astria Therapeutics Inc. stock maintain dividend yield2025 Key Lessons & Breakout Confirmation Alerts - newser.com
Finanzdaten der Astria Therapeutics Inc-Aktie (ATXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):